A randomized comparison of the terms estimated average glucose versus hemoglobin A1C

Diabetes Educator

Volumn 35, Issue 4, 2009, Pages 596-602

  Brick, Jessica C ^a   Derr, Rachel L ^a   Saudek, Christopher D ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; EDUCATIONAL STATUS; ETHNIC GROUP; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; TELEPHONE;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS; EDUCATIONAL STATUS; ETHNIC GROUPS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; TELEPHONE;

EID: 69549138587     PISSN: 01457217     EISSN: 15546063     Source Type: Journal    
DOI: 10.1177/0145721709336298     Document Type: Article

References (25)

1. Saudek CD, Derr RL, Kalyani RR. Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA. 2006;295:1688-1697.
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
4. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care. 2008;31(Suppl 1):S12-S54.
5. Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the diabetes control and complications trial. Diabetes Care. 2002;25:275-278.
6. Nathan DM, Kuenen J, Borg R, et al. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008; 31:1473-1478
7. Jeppsson JO, Kobold U, Barr J, et al. Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med. 2002;40:78-89.
8. Hoelzel W, Weykamp C, Jeppsson JO, et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem. 2004;50: 166-174.
9. Sacks DB, ADA/EASD/IDF Working Group of the HbA1c Assay. Global harmonization of hemoglobin A1c. Clin Chem. 2005; 51:681-683.
10. Consensus Committee. Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American diabetes association, European association for the study of diabetes, international federation of clinical chemistry and laboratory medicine, and the international diabetes federation. Diabetes Care. 2007;30:2399-2400.
11. Harwell TS, Dettori N, McDowall JM, et al. Do persons with diabetes know their (A1C) number? Diabetes Educ. 2002; 28:99-105.
12. Do DV, Nguyen QD, Bressler NM, et al. Hemoglobin A1c awareness among patients receiving eye care at a tertiary ophthalmic center. Am J Ophthalmol. 2006;141:951-953.
13. Guirguis LM, Kieser MA, Chewning BA, Kanous NL. Recall of A1C, blood pressure, and cholesterol levels among community pharmacy patients with diabetes. J Am Pharm Assoc (2003). 2007;47:29-34.
14. van den Arend IJ, Stolk RP, Rutten GE, Schrijvers GJ. Education integrated into structured general practice care for type 2 diabetic patients results in sustained improvement of disease knowledge and self-care. Diabet Med. 2000;17:190-197.
15. Heisler M, Piette JD, Spencer M, Kieffer E, Vijan S. The relationship between knowledge of recent HbA1c values and diabetes care understanding and self-management. Diabetes Care. 2005;28: 816-822.
16. Berikai P, Meyer PM, Kazlauskaite R, Savoy B, Kozik K, Fogelfeld L. Gain in patients' knowledge of diabetes management targets is associated with better glycemic control. Diabetes Care.2007;30:1587-1589.
17. Barth JH, Marshall SM, Watson ID. Consensus meeting on reporting glycated haemoglobin and estimated average glucose in the UK: report to the national director for diabetes, department of health. Ann Clin Biochem. 2008;45:343-344.
18. Roberts WL, Safar-Pour S, De BK, Rohlfing CL, Weykamp CW, Little RR. Effects of hemoglobin C and S traits on glycohemoglobin measurements by eleven methods. Clin Chem. 2005;51:776-778.
19. Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med. 1976;295:417-20.
20. Tahara Y, Shima K. The response of GHb to stepwise plasma glucose change over time in diabetic patients. Diabetes Care. 1993;16:1313-1314.
21. Tahara Y, Shima K. Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care. 1995;18: 440-447.
22. Derr R, Garrett E, Stacy GA, Saudek CD. Is HbA(1c) affected by glycemic instability? Diabetes Care. 2003;26:2728-2733.
23. Herman WH, Ma Y, Uwaifo G, et al. Racial and ethnic differences in hemoglobin A1c among patients with impaired glucose tolerance in the diabetes prevention program. Diabetes Care. 2009 [Epub ahead of print].
24. Introduction. Diabetes Care. 2006;29(Suppl 1):S1-S2.
25. Pani LN, Korenda L, Meigs JB, et al. Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham offspring study and the national health and nutrition examination survey 2001-2004. Diabetes Care. 2008;31:1991-1996.